Specialist pharma company Warner Chilcott is to buy Procter & Gamble's pharmaceutical division for $3.1 billion, turning it into a …
Pfizer is hoping to unlock the power of online communities to help it recruit more people for clinical trials.Pfizer has …
Pharmafocus presents its periodic round-up of developments in the contract research sector, including updates from Covance, CenterWatch, Pharm-Olam and JSS …
GlaxoSmithKline says the public need not doubt the safety of its vaccine against the H1N1 swine flu, which it is …
Avastin's rise continues as new data suggests it improves progression-free survival as a second line treatment for advanced breast cancer.The …
The Manchester Biomedical Research Centre (BRC) has appointed a new industry-facing executive to forge new research links with the industry.Dr …
Novartis has received US approval for its betaferon product for multiple sclerosis.Extavia’s active ingredient is interferon beta-1b, putting it into …
The US industry is accused of selling out to President Obama’s healthcare take-over, with its leaders seeking favourable treatment from …
Australian company Amcor looks set to join the healthcare packaging giants via a $2 billion deal to purchase the pharmaceutical, …
A new report is pressing for the off label prescribing of drugs to be made clearer and more fair for …
Accounting errors at recently-acquired ClinPhone pegged back Parexel's operating profits in its latest quarterly reports, and it will be some …
GSK is to embark on the clinical development for its pandemic swine flu vaccine, completing enrolment into its first study …
The shortage of Genzyme's enzyme replacement therapy Cerezyme look set to last longer than expected, as the company has taken …
The first 11 million people to receive jabs against the H1N1 virus have been announced by the government, ready for …
Pharmafocus' round-up of manufacturing news includes an all-clear for Mylan's Morgantown facility, GSK's flu vaccine plans and updates from the …
UK politicians have thrown their weight behind a Twitter campaign to defend the reputation of the NHS against increasingly virulent …
Patients in the UK have been given the chance to rate hospitals by a variety of criteria using a new …
Novartis chief executive Daniel Vasella has spoken for the first time of his shock at the arson attack on his …
President Obama has hit back at critics of his reform plans, saying their campaigns are using scare tactics to keep …